| Autor: |
Callander JK; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA., Strohl MP; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA., Knott PD; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA., Park A; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA., Seth R; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA., Heaton CM; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA. |
| Abstrakt: |
Background: Infection with hepatitis C virus (HCV) is associated with an increased risk of developing head and neck cancer (HNC), and negatively impacts cancer-specific survival. Objective: To measure the impact of HCV status on free tissue transfer failure, flap takeback, and length of stay in HNC patients undergoing reconstruction. Methods: We retrospectively reviewed patients who underwent head and neck free tissue transfer reconstruction at a single academic institution between August 2011 and June 2020. Results: In the HCV-infected group, total flap failure rate was 2.9% versus 1.3% in the control group and the takeback rate was 11.1% versus 9.6%. On multivariate analysis, HCV status was not associated with flap failure, flap takeback, or total length of hospital stay >7 days. Conclusion: In this study, HCV status was not associated with differences in postoperative complications or length of stay. Future research with greater numbers of HCV-positive study subjects is required to elucidate the effect of HCV infection in this patient population. |
